Brookfield Renewable Partners LP
BEP.UN
The Toronto-Dominion Bank
TD
BCE Inc
BCE
TC Energy Corp
TRP
Enbridge Inc
ENB
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.